Advertisement

Topics

Varian, Inc. Company Profile

21:19 EST 13th November 2018 | BioPortfolio

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc.'s common stock is traded on the NASDAQ Global Select Market under the symbol "VARI." Further information is available on the company's Web site at http://www.varianinc.com.


News Articles [26 Associated News Articles listed on BioPortfolio]

Varian Forms FlashForward Consortium to Study Ultra-high Dose Rate Cancer Treatments with Protons

PALO ALTO, Calif., Oct. 20, 2018 /PRNewswire/ -- To expand the encouraging preclinical and translational research already conducted by Varian (NYSE: VAR) and two of Read more...

Varian closes deal to buy Noona Healthcare

Varian has announced completion of its acquisition of Noona Healthcare, which develops a cloud-based mobile service for cap -More- 

Varian partners with Mediheal to support cancer care in Kenya

Varian signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya.

Varian announces acquisition of humediQ Global

Privately held humediQ Global has been acquired by Varian Medical Systems as part of its long-term growth and value-creation  -More- 

Varian won't counterbid for Sirtex, maintains $1.28B offer

Varian Medical, which initially offered to buy Sirtex Medical for $1.28 billion, said it won't submit a counterproposal to Ch -More- 

Varian Outlines Strategy for AI-Driven Multimodality Adaptive Radiotherapy Suite

PALO ALTO, Calif., Oct. 21, 2018 /PRNewswire/ -- During its Users Meeting at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting, Varian (NYSE: Read more...

Varian Ranked First in Probability of Repurchase and Overall Manufacturer, System, and Service ...

PALO ALTO, Calif., Oct. 22, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, Read more...

Varian Introduces New ProBeam 360° Proton Therapy System

PALO ALTO, Calif., Oct. 20, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced its new single-room proton therapy system, ProBeam® 360°. With a 30 percent Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

Monte Carlo determination of kQ and kQmsr values for the exradin A26 ionisation chamber for the Varian TrueBeam.

We have calculated conversion factors, k<sub>Q</sub> for the A26 micro ionisation chamber along with machine specific reference beam quality factors, k<sub>Qmsr</sub>, for a nu...

Verification of the TrueBeam Head Shielding Model in Varian VirtuaLinac via Out-of-field Doses.

A good Monte Carlo model with an accurate head shielding model is important in estimating the long term risks of unwanted radiation exposure during radiation therapy. The aim of this paper is to valid...

Evaluation of beam matching accuracy among six linacs from the same vendor.

The purpose of this study was to evaluate the dosimetric variation among six non-beam-matched Varian linacs using different techniques for the same plans. Six non-beam-matched Varian machines, compris...

IMRT/VMAT dose distributions generated for and collimators and accelerators.

The aim of this study is to answer the question whether the calculated dose distributions for HD and Millennium collimators (Varian Medical Systems) are equivalent for large treatment volumes.

Neutron and high energy photon fluence estimation in CLINAC using gold activation foils.

The thermal neutron, epithermal neutron and high-energy photon fluence were measured in this work around the Varian 21EX 23 MV CLINAC, which is operated in Albairouni hospital in Damascus, Syria.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart

This study investigates the Breathe Well device to test whether it is superior to the existing treatment standard of the Varian Realtime Position Management (RPM) system in assisting patie...

Study Evaluating Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.

The Calypso® System (Varian Medical Systems, Inc., Palo Alto, CA) is a recent technology using electromagnetic transponders implanted within the prostate. It is a real-time target trackin...

Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc

Brain metastases are the most common adult intracranial tumor, occurring in approximately 10% to 30% of adult cancer patients, and represent an important cause of morbidity and mortality. ...

Post-radiation Dental Disease Amongst Head and Neck Cancer Patients

Background Post-radiotherapy head and neck cancer (HANC) patients are at increased risk of dental caries and periodontal disease due to radiation-related damage to the teeth and salivary g...

MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases

Bone metastasis give rise to major complications that lead to significant morbidity and impairment of life quality. The most common primary for bone metastasis is prostate, lung and breast...

Companies [11 Associated Companies listed on BioPortfolio]

Nalorac Corporation

On February 15, 2002 Nalorac was acquired by Varian Inc, and will shortly be merged into Varian's NMR Systems business. The group will maintain its focus on providing innovative, high-performance prob...

Varian, Inc.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provide...

Varian, Inc

At Varian, Inc. we’re guided by several principles that define what we do, and how we do it. Our ValuesOur values guide the way we do business–our customers, suppliers and employees see them in ac...

Varian Medical Systems

December 12th, 1986, creation of the company by Bernard GALLIOT and Pierre FRAGNAC 1987, Vincent BÉDAT joined the company; the first information system is installed at Angoulême’s hospital (France...

Varian Medical Systems, Inc.

More Information about "Varian, Inc." on BioPortfolio

We have published hundreds of Varian, Inc. news stories on BioPortfolio along with dozens of Varian, Inc. Clinical Trials and PubMed Articles about Varian, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Varian, Inc. Companies in our database. You can also find out about relevant Varian, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record